ADOLOR (NASDAQ:ADLR)
1.51
+0.01 (0.67%)
| ADOLOR (NASDAQ:ADLR) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $1.50 | 52 Week High | $2.55 | ||
| Open | $1.49 | 52 Week Low | $1.27 | ||
| Day High | $1.54 | P/E | N/A | ||
| Day Low | $1.49 | EPS | $-1.21 | ||
| Volume | 110,538 | ||||
| More ADLR Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GSK | 4 | LLY | 3 |
| NDSN | 2 | BRCD | 2 |
| PFE | 2 | CRM | 2 |
| HIBB | 2 | ZIGO | 2 |
| MENT | 2 | NANO | 2 |
| MATK | 1 | FSC | 1 |
Entities who have mentioned ADLR
- Brean Murray Carret & Co. | View Related Stories »
- After-Hours Movers | View Related Stories »
- Scopia Capital | View Related Stories »
- Jefferies & Co | View Related Stories »
- Dividend | View Related Stories »
- UBS | View Related Stories »
- 13G | View Related Stories »
- Deutsche Bank | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- Soleil Securities | View Related Stories »
- Piper Jaffray | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Bankruptcy | View Related Stories »
- Layoffs | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- RBC Capital | View Related Stories »
- Morgan Stanley | View Related Stories »
View All Major News StreetInsider.com Major News for ADLR
- Adolor Corp. (ADLR) Posts Q3 Loss of $0.24, Misses Estimates
- Adolor (ADLR) Reports In-Line Q2 Loss of $0.36
- Adolor (ADLR) Misses Q1 View By 3c
View All ReportsStreetInsider.com Reports on ADLR
- Adolor Corp. (ADLR) Posts Q3 Loss of $0.24, Misses Estimates
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- After-Hours Movers 9/21: OCLR, CIM, ADLR Higher; AMR, DDRX, FSX, LPX, EPD, LINC Lower
- Adolor (ADLR) Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company (LLY)
- Adolor (ADLR) Acquires Exclusive Worldwide Rights to OpRA III From Eli Lilly (LLY)
View All Press ReleasesCompany Press Releases on ADLR
- Adolor Corporation Initiates Clinical Testing in Opioid Bowel Dysfunction Program
- Adolor Corporation Reports Third Quarter 2009 Financial Results
- Adolor Corporation to Host Investor Conference Call To Report Third Quarter 2009 Financial Results
StreetInsider Reports on ADLR by Category
View All BlogsBlogs on ADLR
- Progenics: Are the Prospects That Bad?
- Adolor Corp. Q3 2009 Earnings Conference Call
- 11 Ache-free Investment Opportunities in Neuropathic Pain
- Adolor Corporation Q2 2009 Earnings Call Transcript
- Adolor Corporation, Q1 2009 Earnings Call Transcript
View All FilingsSEC Filings on ADLR
- Form 10-Q ADOLOR CORP For: Sep 30
- Form 8-K ADOLOR CORP For: Oct 29
- Form 4 ADOLOR CORP For: Sep 22 Filed by: LAMPERT MARK N
- Form SC 13G/A ADOLOR CORP Filed by: BIOTECHNOLOGY VALUE FUND L P
- Form 8-K ADOLOR CORP For: Sep 18
Comments on ADLR
No comments are currently available.
